https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K213944
Related Posts
Cassava Sciences Responds To Media Reports; Says ‘In November 2021, Cassava Sciences previously disclosed that certain government agencies had asked for corporate information and at that time, the media widely reported on these prior disclosures.’
- In November 2021, Cassava Sciences previously disclosed that certain government agencies had asked for corporate information and at that time, the media widely reported on these prior disclosures.
- No
MKM Partners Downgrades Spirit Airlines to Neutral, Announces $25 Price Target
MKM Partners analyst Conor Cunningham downgrades Spirit Airlines (NYSE:SAVE) from Buy to Neutral and announces $25 price target.
Piper Sandler Maintains Overweight on Pathward Financial, Lowers Price Target to $54
Piper Sandler analyst Frank Schiraldi maintains Pathward Financial (NASDAQ:CASH) with a Overweight and lowers the price target from $55 to $54.